H. Pylori exploits and manipulates innate and adaptive immune cell signaling pathways to establish persistent infection

Cell Communication and Signaling

Volumn 9, Issue , 2011, Pages

  Müller, Anne ^a   Oertli, Mathias ^a   Arnold, Isabelle C ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

immune evasion; immunomodulation; innate immune signaling; persistent infection

Indexed keywords

ADAPTIVE IMMUNITY; CANCER RISK; CELL TYPE; DISEASE PREDISPOSITION; GASTRITIS; HELICOBACTER PYLORI; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOLOGY; INNATE IMMUNITY; NONHUMAN; PATTERN RECOGNITION; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

BACTERIA (MICROORGANISMS); HELICOBACTER PYLORI;

EID: 84859954142     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-9-25     Document Type: Review

References (56)

1. Host innate immune receptors and beyond: making sense of microbial infections. KJ Ishii, S Koyama, A Nakagawa, C Coban, S Akira, Cell Host Microbe 2008 3 352 363 10.1016/j.chom.2008.05.003 18541212 (Pubitemid 351773099)
2. NLR-mediated control of inflammasome assembly in the host response against bacterial pathogens. IE Brodsky, D Monack, Semin Immunol 2009 21 199 207 10.1016/j.smim.2009.05.007 19539499
3. Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection. B Schmausser, M Andrulis, S Endrich, SK Lee, C Josenhans, HK Muller-Hermelink, M Eck, Clin Exp Immunol 2004 136 521 526 10.1111/j.1365-2249.2004.02464.x 15147355 (Pubitemid 38703687)
4. Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. S Ishihara, MA Rumi, Y Kadowaki, CF Ortega-Cava, T Yuki, N Yoshino, Y Miyaoka, H Kazumori, N Ishimura, Y Amano, Y Kinoshita, J Immunol 2004 173 1406 1416 15240737 (Pubitemid 38924322)
5. Helicobacter pylori flagellin evades toll-like receptor 5-mediated innate immunity. AT Gewirtz, Y Yu, US Krishna, DA Israel, SL Lyons, RM Peek Jr, J Infect Dis 2004 189 1914 1920 10.1086/386289 15122529 (Pubitemid 38657228)
6. Evasion of Toll-like receptor 5 by flagellated bacteria. E Andersen-Nissen, KD Smith, KL Strobe, SL Barrett, BT Cookson, SM Logan, A Aderem, Proc Natl Acad Sci USA 2005 102 9247 9252 10.1073/pnas.0502040102 15956202 (Pubitemid 40923549)
7. Structural characterization of the lipid A component of Helicobacter pylori rough- and smooth-form lipopolysaccharides. AP Moran, B Lindner, EJ Walsh, J Bacteriol 1997 179 6453 6463 9335296 (Pubitemid 27443930)
8. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. MF Smith Jr, A Mitchell, G Li, S Ding, AM Fitzmaurice, K Ryan, S Crowe, JB Goldberg, J Biol Chem 2003 278 32552 32560 10.1074/jbc.M305536200 12807870 (Pubitemid 37055693)
9. A commensal Helicobacter sp. of the rodent intestinal flora activates TLR2 and NOD1 responses in epithelial cells. N Chaouche-Drider, M Kaparakis, A Karrar, MI Fernandez, LA Carneiro, J Viala, IG Boneca, AP Moran, DJ Philpott, RL Ferrero, PLoS One 2009 4 5396 10.1371/journal.pone.0005396 19401779
10. Extracellular and intracellular pattern recognition receptors cooperate in the recognition of Helicobacter pylori. R Rad, W Ballhorn, P Voland, K Eisenacher, J Mages, L Rad, R Ferstl, R Lang, H Wagner, RM Schmid, et al. Gastroenterology 2009 136 2247 2257 10.1053/j.gastro.2009.02.066 19272387
11. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. A Sayi, E Kohler, IM Toller, RA Flavell, W Muller, A Roers, A Muller, J Immunol 2011 186 878 890 10.4049/jimmunol.1002269 21149607
12. Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori. SI Gringhuis, J den Dunnen, M Litjens, M van der Vlist, TB Geijtenbeek, Nat Immunol 2009 10 1081 1088 10.1038/ni.1778 19718030
13. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. M Chamaillard, M Hashimoto, Y Horie, J Masumoto, S Qiu, L Saab, Y Ogura, A Kawasaki, K Fukase, S Kusumoto, et al. Nat Immunol 2003 4 702 707 10.1038/ni945 12796777 (Pubitemid 36874448)
14. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. SE Girardin, IG Boneca, LA Carneiro, A Antignac, M Jehanno, J Viala, K Tedin, MK Taha, A Labigne, U Zahringer, et al. Science 2003 300 1584 1587 10.1126/science.1084677 12791997 (Pubitemid 36682892)
15. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands. YG Kim, JH Park, MH Shaw, L Franchi, N Inohara, G Nunez, Immunity 2008 28 246 257 10.1016/j.immuni.2007.12.012 18261938
16. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. J Viala, C Chaput, IG Boneca, A Cardona, SE Girardin, AP Moran, R Athman, S Memet, MR Huerre, AJ Coyle, et al. Nat Immunol 2004 5 1166 1174 10.1038/ni1131 15489856 (Pubitemid 39549631)
17. Helicobacter pylori induces MAPK phosphorylation and AP-1 activation via a NOD1-dependent mechanism. CC Allison, TA Kufer, E Kremmer, M Kaparakis, RL Ferrero, J Immunol 2009 183 8099 8109 10.4049/jimmunol.0900664 20007577
18. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. A Grubman, M Kaparakis, J Viala, C Allison, L Badea, A Karrar, IG Boneca, L Le Bourhis, S Reeve, IA Smith, et al. Cell Microbiol 12 626 639
19. Helicobacter pylori exploits cholesterol-rich microdomains for induction of NF-kappaB-dependent responses and peptidoglycan delivery in epithelial cells. ML Hutton, M Kaparakis-Liaskos, L Turner, A Cardona, T Kwok, RL Ferrero, Infect Immun 2010 78 4523 4531 10.1128/IAI.00439-10 20713621
20. Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cells. M Kaparakis, L Turnbull, L Carneiro, S Firth, HA Coleman, HC Parkington, L Le Bourhis, A Karrar, J Viala, J Mak, et al. Cell Microbiol 12 372 385
21. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. T Watanabe, N Asano, S Fichtner-Feigl, PL Gorelick, Y Tsuji, Y Matsumoto, T Chiba, IJ Fuss, A Kitani, W Strober, J Clin Invest 120 1645 1662
22. Olfactomedin 4 down-regulates innate immunity against Helicobacter pylori infection. W Liu, M Yan, Y Liu, R Wang, C Li, C Deng, A Singh, WG Coleman Jr, GP Rodgers, Proc Natl Acad Sci USA 2010 107 11056 11061 10.1073/pnas.1001269107 20534456
23. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. AA Akhiani, J Pappo, Z Kabok, K Schon, W Gao, LE Franzen, N Lycke, J Immunol 2002 169 6977 6984 12471132 (Pubitemid 36899285)
24. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. TH Ermak, PJ Giannasca, R Nichols, GA Myers, J Nedrud, R Weltzin, CK Lee, H Kleanthous, TP Monath, J Exp Med 1998 188 2277 2288 10.1084/jem.188.12.2277 9858514 (Pubitemid 29028500)
25. The CD4+ T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. A Sayi, E Kohler, I Hitzler, I Arnold, R Schwendener, H Rehrauer, A Muller, J Immunol 2009 182 7085 7101 10.4049/jimmunol.0803293 19454706
26. An African origin for the intimate association between humans and Helicobacter pylori. B Linz, F Balloux, Y Moodley, A Manica, H Liu, P Roumagnac, D Falush, C Stamer, F Prugnolle, SW van der Merwe, et al. Nature 2007 445 915 918 10.1038/nature05562 17287725
27. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. B Gebert, W Fischer, E Weiss, R Hoffmann, R Haas, Science 2003 301 1099 1102 10.1126/science.1086871 12934009 (Pubitemid 37022312)
28. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. M Boncristiano, SR Paccani, S Barone, C Ulivieri, L Patrussi, D Ilver, A Amedei, MM D'Elios, JL Telford, CT Baldari, J Exp Med 2003 198 1887 1897 10.1084/jem.20030621 14676300 (Pubitemid 38032121)
29. Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion. MS Sundrud, VJ Torres, D Unutmaz, TL Cover, Proc Natl Acad Sci USA 2004 101 7727 7732 10.1073/pnas.0401528101 15128946 (Pubitemid 38658097)
30. Purification and characterization of the vacuolating toxin from Helicobacter pylori. TL Cover, MJ Blaser, J Biol Chem 1992 267 10570 10575 1587837
31. Integrin subunit CD18 Is the T-lymphocyte receptor for the Helicobacter pylori vacuolating cytotoxin. X Sewald, B Gebert-Vogl, S Prassl, I Barwig, E Weiss, M Fabbri, R Osicka, M Schiemann, DH Busch, M Semmrich, et al. Cell Host Microbe 2008 3 20 29 10.1016/j.chom.2007.11.003 18191791
32. PKC-dependent endocytosis of the Helicobacter pylori vacuolating cytotoxin in primary T lymphocytes. X Sewald, L Jimenez-Soto, R Haas, Cell Microbiol 13 482 496
33. A secreted low-molecular-weight protein from Helicobacter pylori induces cell-cycle arrest of T cells. M Gerhard, C Schmees, P Voland, N Endres, M Sander, W Reindl, R Rad, M Oelsner, T Decker, M Mempel, et al. Gastroenterology 2005 128 1327 1339 10.1053/j.gastro.2005.03.018 15887115 (Pubitemid 40712183)
34. Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase. C Schmees, C Prinz, T Treptau, R Rad, L Hengst, P Voland, S Bauer, L Brenner, RM Schmid, M Gerhard, Gastroenterology 2007 132 1820 1833 10.1053/j.gastro.2007.02.031 17484877 (Pubitemid 46677933)
35. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. IC Arnold, JY Lee, MR Amieva, A Roers, RA Flavell, T Sparwasser, A Muller, Gastroenterology 2011 140 199 209 10.1053/j.gastro.2010. 06.047 20600031
36. Dendritic Cells Prevent Rather Than Promote Immunity Conferred by a Helicobacter Vaccine Using a Mycobacterial Adjuvant. I Hitzler, M Oertli, B Becher, EM Agger, A Muller, Gastroenterology 2011 141 186 196 10.1053/j.gastro.2011.04.009 21569773
37. Mucosal FOXP3-expressing CD4+ CD25high regulatory T cells in Helicobacter pylori-infected patients. A Lundgren, E Stromberg, A Sjoling, C Lindholm, K Enarsson, A Edebo, E Johnsson, E Suri-Payer, P Larsson, A Rudin, et al. Infect Immun 2005 73 523 531 10.1128/IAI.73.1.523-531.2005 15618192 (Pubitemid 40041147)
38. Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. A Lundgren, E Suri-Payer, K Enarsson, AM Svennerholm, BS Lundin, Infect Immun 2003 71 1755 1762 10.1128/IAI.71.4.1755-1762.2003 12654789 (Pubitemid 36368704)
39. Helicobacter pylori gastritis in children is associated with a regulatory T-cell response. PR Harris, SW Wright, C Serrano, F Riera, I Duarte, J Torres, A Pena, A Rollan, P Viviani, E Guiraldes, et al. Gastroenterology 2008 134 491 499 10.1053/j.gastro.2007.11.006 18242215 (Pubitemid 351173044)
40. Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. IC Arnold, N Dehzad, S Reuter, H Martin, B Becher, C Taube, A Muller, J Clin Invest 2011 121 3088 3093 10.1172/JCI45041 21737881
41. Does Helicobacter pylori protect against asthma and allergy? MJ Blaser, Y Chen, J Reibman, Gut 2008 57 561 567 10.1136/gut.2007.133462 18194986 (Pubitemid 351579962)
42. Inverse associations of Helicobacter pylori with asthma and allergy. Y Chen, MJ Blaser, Arch Intern Med 2007 167 821 827 10.1001/archinte.167.8.821 17452546 (Pubitemid 46658341)
43. Helicobacter pylori colonization is inversely associated with childhood asthma. Y Chen, MJ Blaser, J Infect Dis 2008 198 553 560 10.1086/590158 18598192
44. Asthma is inversely associated with Helicobacter pylori status in an urban population. J Reibman, M Marmor, J Filner, ME Fernandez-Beros, L Rogers, GI Perez-Perez, MJ Blaser, PLoS One 2008 3 4060 10.1371/journal.pone.0004060 19112508
45. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease-antibiotic use in the history does not play a significant role. L Pronai, L Schandl, Z Orosz, P Magyar, Z Tulassay, Helicobacter 2004 9 278 283 10.1111/j.1083-4389.2004.00223.x 15165265 (Pubitemid 38724765)
46. [The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent]. M Sladek, U Jedynak-Wasowicz, A Wedrychowicz, K Kowalska-Duplaga, S Pieczarkowski, K Fyderek, Przegl Lek 2007 64 Suppl 3 65 67 18431918
47. Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis: Mucosal crosstalk between stomach and distal intestine. PD Higgins, LA Johnson, J Luther, M Zhang, KL Sauder, LP Blanco, JY Kao, Inflamm Bowel Dis 17 1398 408
48. How tolerogenic dendritic cells induce regulatory T cells. RA Maldonado, UH von Andrian, Adv Immunol 2010 108 111 165 21056730
49. Inducing and expanding regulatory T cell populations by foreign antigen. K Kretschmer, I Apostolou, D Hawiger, K Khazaie, MC Nussenzweig, H von Boehmer, Nat Immunol 2005 6 1219 1227 10.1038/ni1265 16244650 (Pubitemid 43045633)
50. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. JY Kao, M Zhang, MJ Miller, JC Mills, B Wang, M Liu, KA Eaton, W Zou, BE Berndt, TS Cole, et al. Gastroenterology 2010 138 1046 1054 10.1053/j.gastro.2009.11.043 19931266
51. Helicobacter pylori impairs murine dendritic cell responses to infection. YH Wang, JP Gorvel, YT Chu, JJ Wu, HY Lei, PLoS One 2010 5 10844 10.1371/journal.pone.0010844 20523725
52. Helicobacter pylori-specific antibodies impair the development of gastritis, facilitate bacterial colonization, and counteract resistance against infection. AA Akhiani, K Schon, LE Franzen, J Pappo, N Lycke, J Immunol 2004 172 5024 5033 15067084 (Pubitemid 38456429)
53. Vaccine-induced protection against Helicobacter pylori in mice lacking both antibodies and interleukin-4. CA Garhart, JG Nedrud, FP Heinzel, NE Sigmund, SJ Czinn, Infect Immun 2003 71 3628 3633 10.1128/IAI.71.6.3628-3633. 2003 12761151 (Pubitemid 36637595)
54. IgA antibodies impair resistance against Helicobacter pylori infection: studies on immune evasion in IL-10-deficient mice. AA Akhiani, A Stensson, K Schon, NY Lycke, J Immunol 2005 174 8144 8153 15944323 (Pubitemid 40806326)
55. The peopling of the Pacific from a bacterial perspective. Y Moodley, B Linz, Y Yamaoka, HM Windsor, S Breurec, JY Wu, A Maady, S Bernhoft, JM Thiberge, S Phuanukoonnon, et al. Science 2009 323 527 530 10.1126/science.1166083 19164753
56. NOD1-Mediated Mucosal Host Defense against Helicobacter pylori. T Watanabe, N Asano, A Kitani, IJ Fuss, T Chiba, W Strober, Int J Inflam 2010 476482